Skip to content

A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis.

A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03416985
Enrollment
90
Registered
2018-01-31
Start date
2018-01-02
Completion date
2018-12-30
Last updated
2019-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque, Dental Plaque Induced Gingivitis

Brief summary

It is well accepted that the greatest contributor to the health of the periodontium and dentition is regular and thorough dental plaque removal, typically by means of adequate toothbrushing. Although patients are typically informed about the risks of substandard oral hygiene and the contributing factors in oral/dental disease by dental professionals, research has shown that an undesirably high proportion of adults find thorough toothbrushing with a standard manual toothbrush to achieve a plaque-free state challenging, as evidenced by high worldwide levels of gingivitis and/or periodontitis.

Detailed description

The purpose of this study is to clinically evaluate the plaque removal efficacy of two electric powered toothbrushes after a single use, as well as the effect on plaque accumulation and gingivitis after 14 days and 30 days period. Simultaneously, a comparison against a manual toothbrush will be made. Study design: randomised, single blinded, parallel. After the screening procedure and based on inclusion requirements, all subjects will receive oral prophylaxis (T0) to ensure a baseline of 0 Plaque Index (PI) prior to the first appointment (T1). The subjects will be instructed not to use a tooth brush or any mechanical cleaning device until the initial PI and Gingival Indexes (GI) are taken at 24 hours after T0. The subjects will be randomized into 3 groups, and the will be provided one of the three evaluated toothbrushes, as well as toothpaste. All subjects will be using identical toothpaste and will receive oral hygiene instructions based on the manufacturer's recommendations. At T1 initial GI and PI will be taken prior to brushing followed by a second PI reading immediately after the first use of the power driven toothbrush. The subjects will be instructed to brush twice a day for a period of 2 minutes (following the programmed toothbrush timer) and refrain from using dental floss, tooth pick or any mechanical oral hygiene aid for the period of the study. On the second visit at 14 days (T2) and third visit at 30 days (T3), additional GI and PI readings will be taken and data will be recorded. All measurements and clinical examinations will be performed by a single blinded examiner. Evaluation on teeth will be made on six teeth #3,7,12,19,23 and 28 (mesio-buccal, buccal, disto-buccal and mesio-lingual, lingual, disto-lingual) following the Silness-Loe Index.

Interventions

DEVICEOral B Healthy Clean Manual Toothbrush

Manual Toothbrush

DEVICEBURST Sonic Oral Care

Electric sonic toothbrush

DEVICEPhilipps Sonicare DiamondClean 300 Series

Electric pulsating toothbrush

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Good overall health 2. At least 20 teeth present, not including 3rd Molars 3. Non-smoker

Exclusion criteria

1. Poor manual dexterity or mentally handicap; 2. Presence of removable intra-oral prosthesis 3. Current orthodontic therapy 4. Severe Periodontal condition or caries teeth in need of immediate attention 5. Pregnant women 6. Subjects that use medications that may effect oral health 7. No Systemic diseases/conditions such as diabetes mellitus, heart disease. 8. Use of plaque inhibiting toothpaste, mouthwash, interdental flossing in the period of the study

Design outcomes

Primary

MeasureTime frameDescription
Plaque IndexBaseline, 1 monthplaque index as evaluated by Silness-Loe Index: index recording both soft debris and mineralized deposits on teeth (index 0 (no plaque) to 3).
Gingival IndexBaseline, 1 monthgingival index as evaluated by Silness-Loe Index, Range 0-3: Score 0 = Normal gingiva. Score 1 = Mild inflammation - slight change in color, slight edema. No bleeding on probing. Score 2 = Moderate inflammation - redness, edema, glazing. Bleeding on probing. Score 3 = Severe inflammation - marked redness and edema, ulceration. Tendency toward spontaneous bleeding.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pulsating Toothbrush
Patients were asked to use a pulsating toothbrush for 30 days Philipps Sonicare DiamondClean 300 Series: Electric pulsating toothbrush
28
Sonic Toothbrush
Patients were asked to use a sonic toothbrush for 30 days BURST Sonic Oral Care: Electric sonic toothbrush
30
Manual Toothbrush
Patients were asked to use a manual toothbrush for 30 days Oral B Healthy Clean Manual Toothbrush: Manual Toothbrush
24
Total82

Baseline characteristics

CharacteristicTotalSonic ToothbrushManual ToothbrushPulsating Toothbrush
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
82 Participants30 Participants24 Participants28 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
82 participants30 participants24 participants28 participants
Sex: Female, Male
Female
49 Participants19 Participants14 Participants16 Participants
Sex: Female, Male
Male
33 Participants11 Participants10 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 280 / 300 / 24
other
Total, other adverse events
0 / 280 / 300 / 24
serious
Total, serious adverse events
0 / 280 / 300 / 24

Outcome results

Primary

Gingival Index

gingival index as evaluated by Silness-Loe Index, Range 0-3: Score 0 = Normal gingiva. Score 1 = Mild inflammation - slight change in color, slight edema. No bleeding on probing. Score 2 = Moderate inflammation - redness, edema, glazing. Bleeding on probing. Score 3 = Severe inflammation - marked redness and edema, ulceration. Tendency toward spontaneous bleeding.

Time frame: Baseline, 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Pulsating ToothbrushGingival IndexBaseline0.42 units on a scaleStandard Deviation 0.41
Pulsating ToothbrushGingival Index1 Month0.22 units on a scaleStandard Deviation 0.16
Sonic ToothbrushGingival IndexBaseline0.35 units on a scaleStandard Deviation 0.41
Sonic ToothbrushGingival Index1 Month0.16 units on a scaleStandard Deviation 0.16
Manual ToothbrushGingival IndexBaseline0.36 units on a scaleStandard Deviation 0.39
Manual ToothbrushGingival Index1 Month0.14 units on a scaleStandard Deviation 0.13
Comparison: Compare groups with respect to Gingival scores at 30 daysp-value: 0.2161ANOVA
Primary

Plaque Index

plaque index as evaluated by Silness-Loe Index: index recording both soft debris and mineralized deposits on teeth (index 0 (no plaque) to 3).

Time frame: Baseline, 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Pulsating ToothbrushPlaque Index1 Month1.11 units on a scaleStandard Deviation 0.27
Pulsating ToothbrushPlaque IndexBaseline1.07 units on a scaleStandard Deviation 0.24
Sonic ToothbrushPlaque Index1 Month1.27 units on a scaleStandard Deviation 0.4
Sonic ToothbrushPlaque IndexBaseline1.19 units on a scaleStandard Deviation 0.25
Manual ToothbrushPlaque IndexBaseline1.31 units on a scaleStandard Deviation 0.27
Manual ToothbrushPlaque Index1 Month1.20 units on a scaleStandard Deviation 0.24
Comparison: Compare groups with respect to plaque level after 30 daysp-value: 0.1561ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026